Global Gastric Electric Stimulators Market Size, Share, and Trends Analysis Report – Industry Overview and Forecast to 2032

Gastric Electric Stimulators Market Analysis

The gastric electric stimulators (GES) market has seen significant advancements in both methods and technology. A key innovation is the development of advanced, implantable gastric stimulators that use electrical pulses to regulate gastric motility, especially in patients with conditions such as gastroparesis. These devices now feature smaller, more efficient, and customizable programming options, allowing for better management of symptoms. In addition, wireless and remote monitoring technologies are enhancing the overall functionality of these stimulators, allowing healthcare providers to adjust treatment parameters remotely, improving patient outcomes.

The growth in the gastric electric stimulators market is largely driven by the rising incidence of gastrointestinal disorders, particularly gastroparesis, and the increasing acceptance of minimally invasive treatments. Technological advancements, such as biocompatible materials and longer battery life, are also contributing to the market's expansion. Furthermore, clinical studies supporting the efficacy of GES in treating chronic conditions are fueling demand. As the global healthcare infrastructure advances and the aging population grows, the market for gastric electric stimulators is poised to continue its upward trajectory, providing patients with more effective treatment options.

Gastric Electric Stimulators Market Size

The global gastric electric stimulators market size was valued at USD 300.53 million in 2024 and is projected to reach USD 497.37 million by 2032, with a CAGR of 6.5% during the forecast period of 2025 to 2032. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Gastric Electric Stimulators Market Trends

“Increasing Adoption of Gastric Electric Stimulation for Obesity Treatment”

A significant trend driving growth in the gastric electric stimulators market is the increasing adoption of these devices for obesity treatment. Gastric electric stimulation (GES) is gaining popularity as a minimally invasive therapy for patients with morbid obesity, especially for those who haven't responded to conventional weight-loss methods. These devices work by sending electrical impulses to the stomach, reducing hunger sensations and improving gastric motility. For instance, the EnteroMedics' vBloc device has demonstrated promising results, leading to broader clinical adoption and FDA approvals. As obesity rates rise globally, the demand for effective solutions such as gastric electric stimulators is expected to continue growing.

Report Scope and Gastric Electric Stimulators Market Segmentation

Gastric Electric Stimulators Market Definition

Gastric electric stimulators (GES) are medical devices used to treat chronic nausea, vomiting, and certain gastrointestinal disorders, particularly in patients with gastroparesis. These devices work by delivering electrical pulses to the stomach muscles, helping to stimulate and regulate gastric motility, improving food movement through the digestive tract. The GES is implanted surgically under the skin, typically near the abdomen, with leads placed in the stomach. This therapy is particularly effective in cases where traditional treatments such as medications have failed, offering patients relief and improving their quality of life. It is often used when other treatments are ineffective or intolerable.

Gastric Electric Stimulators Market Dynamics

Drivers

• Increasing Prevalence of Gastrointestinal Disorders

The increasing prevalence of gastrointestinal disorders, particularly conditions such as gastroparesis and chronic indigestion, is a key driver for the gastric electric stimulators market. Gastroparesis, a condition where the stomach cannot empty properly, affects millions of people worldwide, especially those with diabetes. This leads to symptoms such as nausea, vomiting, and bloating, driving the need for effective treatments. Gastric electric stimulators, which help improve stomach motility by delivering electrical impulses to the stomach muscles, offer a solution to these issues. For instance, the FDA-approved Enterra Therapy, a gastric electric stimulator, has been widely used to treat gastroparesis and has shown significant improvement in patient outcomes, driving market growth.

• Growing Preference for Personalized Medicine

The growing preference for personalized medicine significantly impacts the gastric electric stimulators market. These devices offer customizable therapy options, enabling tailored treatments based on individual patient needs, particularly for conditions such as gastroparesis and chronic nausea. By adjusting stimulation settings, healthcare providers can optimize treatment to match the severity of symptoms, improving patient outcomes. This ability to personalize care enhances patient satisfaction and fosters wider acceptance among both clinicians and patients. As healthcare moves toward more individualized treatments, gastric electric stimulators are becoming a preferred option, thus driving increased market demand and adoption across various regions, especially in developed healthcare systems.

Opportunities

• Non-Invasive Treatment Options

The growing preference for non-invasive treatments over surgical options is creating significant opportunities in the gastric electric stimulators market. Different from invasive procedures such as gastric bypass surgery, gastric electric stimulators offer a less risky and more convenient alternative for patients with gastrointestinal disorders, particularly gastroparesis. These devices work by delivering mild electrical pulses to the stomach muscles, promoting motility and easing symptoms without the need for major surgery. As patients seek less traumatic, cost-effective options with quicker recovery times, the demand for gastric electric stimulators is expected to rise, thus fostering growth in the market. This trend is particularly evident in developed healthcare systems where non-invasive treatments are increasingly prioritized.

• Rising Awareness of Gastric Electric Stimulators

As awareness of gastric electric stimulators increases, both among patients and healthcare professionals, the adoption of these devices is growing, especially among individuals with severe gastric motility disorders such as gastroparesis. Educational campaigns and advancements in medical research have highlighted the benefits of gastric electric stimulation, emphasizing its effectiveness in managing symptoms such as nausea, vomiting, and delayed gastric emptying. This heightened awareness opens up significant market opportunities, as more patients seek alternative treatments that improve quality of life without invasive surgeries. As healthcare providers recognize its potential, the demand for gastric electric stimulators is expected to grow, driving market expansion and attracting investments in research and development.

Restraints/Challenges

• High Cost of Treatment

Gastric electric stimulators (GES) are costly, encompassing both the initial device price and ongoing maintenance. The high costs associated with GES limit its accessibility, especially in emerging markets where healthcare budgets are often constrained. Patients in these regions may not afford the treatment, leading to a slower adoption rate. Furthermore, the cost burden extends to healthcare providers who may be reluctant to invest in such expensive devices, further impeding market growth. As the financial strain of acquiring and maintaining GES remains a significant barrier, many potential users are unable to benefit from this treatment, ultimately hindering the expansion of the market.   

• Risk of Complications

The risk of complications associated with gastric electric stimulators (GES) poses a significant challenge to the market. Implantation of GES involves surgery, which carries inherent risks such as infection, device malfunction, and unwanted side effects such as nausea, abdominal discomfort, and even unintended gastric issues. These complications can deter patients from opting for the procedure and may lead healthcare providers to hesitate in recommending GES as a treatment option. The potential for such adverse outcomes raises concerns about patient safety and device reliability, ultimately hindering the adoption of gastric electric stimulators. This contributes to slower market growth and adoption in comparison to other treatments.

This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Gastric Electric Stimulators Market Scope

The market is segmented on the basis of category, product type, indication and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product Type

• High Frequency GES Devices
• Low Frequency GES Devices

 Indication

• Gastroparesis
• Obesity
• Refractory Nausea
• Others

 End User

• Hospitals
• Ambulatory Surgical Centres (ASC’s)
• Outpatients Center

Gastric Electric Stimulators Market Regional Analysis

The market is analysed and market size insights and trends are provided by country, product type, indication and end user as referenced above.

The countries covered in the market report are U.S., Canada, Mexico in North America, Germany, Sweden, Poland, Denmark, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe in Europe, Japan, China, India, South Korea, New Zealand, Vietnam, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in Asia-Pacific (APAC), Brazil, Argentina, Rest of South America as a part of South America, U.A.E, Saudi Arabia, Oman, Qatar, Kuwait, South Africa, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA)

North America is expected to dominate the gastric electric stimulators market due to a growing number of gastrointestinal surgical procedures and the rising prevalence of gastroparesis. The region benefits from favorable regulatory frameworks and reimbursement policies, which further facilitate market expansion. In addition, the increasing awareness of advanced treatment options for gastric disorders and the presence of key players in the healthcare industry contribute to North America's leading position in the market.

Asia-Pacific is expected to show significant growth in the gastric electric stimulators market during the forecast period. This growth is driven by the region’s large population, the increasing adoption of western lifestyles, and the rising prevalence of chronic disorders such as gastrointestinal issues, obesity, and diabetes. As healthcare awareness improves and the demand for advanced treatment options grows, gastric electric stimulators are becoming a preferred choice for managing digestive disorders.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Gastric Electric Stimulators Market Share

The market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to market.

Gastric Electric Stimulators Market Leaders Operating in the Market Are:

• ANS (U.S.)
• EnteroMedics (U.S.)
• IntraPace (U.S.)
• Medtronic (Ireland)
• MetaCure (U.S.)
• Changzhou Rishena Medical Device Co., Ltd (China)
• Stryker Corporation (U.S.)
• ReShape Lifesciences, Inc. (U.S.)
• Philips (Netherlands)

Latest Developments in Gastric Electric Stimulators Market

• In March 2024, Medtronic partnered with Google to integrate artificial intelligence (AI) into gastric electrical stimulators. This strategic collaboration aims to create devices that dynamically adjust to patient-specific needs, enhancing treatment personalization and effectiveness. Leveraging AI, this initiative seeks to redefine innovation in medical devices, setting a benchmark for patient care advancements and improving outcomes significantly
• In December 2023, The FDA granted conditional approval to Enterra Medical’s implantable electrical stimulation device, addressing gastroparesis symptoms such as nausea and vomiting. The Enterra II system, comprising the Enterra 37800 Neurostimulator and Enterra Therapy 4351-35 unipolar leads, offers promising symptom relief. This approval highlights advancements in managing gastroparesis, showcasing the device's potential to improve patient quality of life

SKU-28543